Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus pethidine for post-anesthesia shivering
IRCT20150125020795N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and pethidine in postanesthetic shivering (PAS) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Time required for shivering, Minimum dose needed to stop shivering and 1 more. Started Sep 2019; status: completed.
02
Drugs
dexmedetomidinepethidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20150125020795N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150125020795N4.